ArticleBlood2025

Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes.

Jacqueline S Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.